Suppression of Oncoprotein Her-2 and DNA Damage after Treatment with Flavan-3- ol Vitis labrusca Extract

E-ISSN： 1875-5992|13|7|1088-1095

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.7, 2013-09, pp. : 1088-1095

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective anticancer activity of hirsutine against HER2positive breast cancer cells by inducing DNA damage

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 2072-2076

Spandidos Publications

Access to resources Recommend Favorite

Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

By Bermont L.

Breast Cancer Research and Treatment, Vol. 63, Iss. 2, 2000-09 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

By Baxevanis Constantin Sotiropoulou Panagiota Sotiriadou Nectaria Papamichail Michael

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 166-175

Springer Publishing Company

Access to resources Recommend Favorite

Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells

By Jung Samil Ohk Jiyeon Jeong Dongjun Li Chengping Lee Soonduck Duan Jingjing Kim Changjin Lim Jong-Seok Yang Young Kim Keun-Il Lee Myeong-Sok

International Journal of Oncology, Vol. 45, Iss. 1, 2014-07 ,pp. : 189-196

Spandidos Publications

Access to resources Recommend Favorite

Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV3 human ovarian carcinoma cells

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1133-1139

Spandidos Publications

Access to resources Recommend Favorite